polaris-news/
11 pages · Updated April 25, 2026
Pages
- QuADD Webinar: Delivering Business Value with Quantum-Aided Drug Design
- Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats
- QuADD Webinar: Find Your Star Molecule
- Hybrid Quantum Approach for Sampling Molecular Fragment Libraries to Discover Novel Therapeutics for Ebola
- An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site
- Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design
- Webinar: Using QuaDD to Accelerate Discovery for Versatile Targets
- Sextant: A New Tool for Designing Custom Molecular Templates for Protein-Protein Interaction Inhibitor Drug Design
- PolarisQB Published A Manuscript Demonstrating The Superiority Of Quantum Computing Over AI In Drug Design
- PolarisQB Demonstrates Advances in Drug Safety Prediction with Quantum-Inspired AI, Enabling Earlier Elimination of Toxic Compounds from Discovery Pipeline
- Polaris Quantum Biotech has been selected as a 2026 winner of the Cleveland Clinic Quantum Innovation Catalyzer Program